Medical device regulation is foundational to innovation, yet navigating it remains complex and fragmented.
Regulatory intelligence today is:
• Distributed across dense guidance documents
• Dependent on individual experience
• Difficult to scale consistently
• Increasingly global and dynamic
As markets expand and technologies evolve, regulatory strategy becomes more complex.
We believe regulatory intelligence should be:
• Structured
• Context-aware
• Scalable
• Globally connected
The goal is not automation of judgment.
The goal is augmentation of expertise.
AI now enables contextual reasoning in complex domains. Regulatory affairs is one of the most strategically important - and under-digitized - functions in MedTech.
regul-AI-te is building the infrastructure layer to support that evolution.

Human-in-the-loop design
AI outputs are structured to support expert oversight and refinement.
Transparency in reasoning
Pathway insights are presented with contextual explanation.
We prioritize accuracy, clarity, and scope discipline.
Regulatory integrity first

regul-AI-te was founded by professionals with deep understanding of medical device regulatory pathways and lifecycle strategy.
Our experience across regulatory planning, pathway evaluation, and strategic alignment revealed a systemic challenge:
Regulatory intelligence remains fragmented and difficult to scale.
Our mission is to build AI-native infrastructure for global regulatory ecosystems - starting with FDA medical devices.
Phase 1: FDA Medical Device Intelligence
Phase 2: EU MDR Expansion
Phase 3: Multi-Market Regulatory Intelligence
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.